Advanced Search
Contact | Corporate | Help

GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection

Sponsors:
  • Gilead Sciences
Phases:
  • Phase II
IndicationsAcronym:
  • Chronic Genotype 1a or 1b HCV Infection
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: GS-5885 tablet
  • Drug: GS-9451 tablet
  • Drug: tegobuvir capsule
  • Drug: ribavirin tablet
  • Drug: placebo matching ribavirin tablet
  • Device: placebo matching tegobuvir capsule
Enrollment:
150

Additional information about NCT01434498.


SourceSolution © 2008-2012